Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information

Investor Relations

NeonMind Biosciences Inc.

Company Overview

NeonMind is an integrated psychedelic drug development and wellness company focused on therapeutic uses of psychedelics to address public health needs including obesity, weight management and mental health. NeonMind has two operating divisions, a pharmaceutical division engaged in drug development research for the potential therapeutic uses of psychedelic compounds, and a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings.

Investor Contact Information


NeonMind Biosciences Inc.
Suite 100 – 295 Robinson Street
Oakville, ON L6J 1G7

Investor Relations

T: +1 (705) 710-NEON / +1 (705) 710-6366

Transfer Agent

Endeavor Trust Corporation
T: 604-559-8908